resveratrolFinding
Resveratrol has no detected effect on aspartate aminotransferase
no difference foundLimited evidenceFinding
01 · The sentence it was drawn from
“Interestingly, the result suggested that there was no significant efficacy of resveratrol on ALT level in NAFLD patients [SMD = −0.16, 95% CI (−0.67, 0.35), p = 0.542], nor was the efficacy in AST [SMD = −0.39, 95% CI (−0.95, 0.16), p = 0.167].”
resveratrol
Aspartate aminotransferase
no difference found
Effect as reported
−0.39standardised mean difference
CI −0.95 to 0.16
- Who
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
- Dose studied
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
Limited evidencePMID 37767399 · 2023
02 · The study
- Study
- meta-analysis
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limitedthis finding
- very limited
- insufficient
03 · The paper
Frontiers in pharmacology04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M3RM66AEDYQ0Y6RZN0H7ZBSD